Nanoviricides, Inc. SEC filings NNVC
Nanoviricides, Inc. has 556 filings in SEC EDGAR's recent list, going back to Nov 14, 2006. Its latest annual report, Form 10-K, was filed on Sep 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 31, 2026 | — |
| EFFECT | Filing | Jun 26, 2026 | — |
| CORRESP | Letter to the SEC | Jun 23, 2026 | — |
| DEL AM | Filing | Jun 22, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2026 | — |
| DEL AM | Filing | Jun 17, 2026 | — |
| EFFECT | Filing | Jun 15, 2026 | — |
| CORRESP | Letter to the SEC | Jun 11, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2026 | — |
| D | Filing | Feb 25, 2026 | — |
| EFFECT | Filing | Dec 19, 2025 | — |
| CORRESP | Letter to the SEC | Dec 18, 2025 | — |
| DEL AM | Filing | Dec 16, 2025 | — |
| UPLOAD | Letter from the SEC | May 13, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| NT 10-K | Filing | Sep 28, 2023 | Jun 30, 2023 |
| EFFECT | Filing | May 22, 2023 | — |
| CORRESP | Letter to the SEC | May 17, 2023 | — |
| UPLOAD | Letter from the SEC | May 12, 2023 | — |
| NT 10-K | Filing | Sep 29, 2022 | Jun 30, 2022 |
| NT 10-K | Filing | Sep 28, 2021 | Jun 30, 2021 |
| NT 10-K | Filing | Sep 28, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Apr 2, 2020 | — |
| CORRESP | Letter to the SEC | Mar 31, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2020 | — |
| EFFECT | Filing | Jan 9, 2020 | — |
| CORRESP | Letter to the SEC | Jan 9, 2020 | — |
| CORRESP | Letter to the SEC | Jan 8, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2019 | — |
| NT 10-Q | Filing | Nov 14, 2019 | Sep 30, 2019 |
| RW | Filing | Nov 6, 2019 | — |
| D | Filing | Mar 8, 2019 | — |
| NT 10-K | Filing | Sep 28, 2018 | Jun 30, 2018 |
| NT 10-Q | Filing | May 15, 2018 | Mar 31, 2018 |
| NT 10-Q | Form 12b-25 | Feb 14, 2018 | Dec 31, 2017 |
| DEFR14A | Filing | Nov 8, 2017 | — |
| EFFECT | Filing | Apr 25, 2017 | — |
| CORRESP | Letter to the SEC | Apr 20, 2017 | — |
| CORRESP | Letter to the SEC | Apr 18, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2017 | — |
| EFFECT | Filing | Apr 14, 2016 | — |
| NT 10-Q | Notification of late filing | May 12, 2015 | Mar 31, 2015 |
| NT 10-Q | Notification of late filing | Feb 17, 2015 | Dec 31, 2014 |
| EFFECT | Filing | Nov 17, 2014 | — |
| CORRESP | Letter to the SEC | Nov 13, 2014 | — |
| CORRESP | Letter to the SEC | Nov 7, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2014 | — |
| NT 10-K | Notification of late filing | Sep 29, 2014 | Jun 30, 2014 |
| EFFECT | Filing | Aug 1, 2014 | — |
| NT 10-Q | Form 12b-25 | Nov 14, 2013 | Sep 30, 2013 |
| NT 10-K | Notification of late filing | Sep 30, 2013 | Jun 30, 2013 |
| CERTNYS | Auto-generated paper document | Sep 23, 2013 | — |
| 8-A12B | Form 8-a12b | Sep 23, 2013 | — |
| D | Filing | Feb 4, 2013 | — |
| EFFECT | Filing | Dec 21, 2012 | — |
| CORRESP | Letter to the SEC | Dec 20, 2012 | — |
| CORRESP | Letter to the SEC | Dec 20, 2012 | — |
| NT 10-Q | Form 12b-25 | Nov 14, 2012 | Sep 30, 2012 |
| UPLOAD | Letter from the SEC | Nov 5, 2012 | — |
| NT 10-K | Notice under rule 12b25 | Sep 28, 2012 | Jun 30, 2012 |
| UPLOAD | Letter from the SEC | Jul 10, 2012 | — |
| CORRESP | Letter to the SEC | Jun 11, 2012 | — |
| CORRESP | Letter to the SEC | May 30, 2012 | — |
| NT 10-Q | Notification of late filing | May 15, 2012 | Mar 31, 2012 |
| CORRESP | Letter to the SEC | Apr 26, 2012 | — |
| CORRESP | Letter to the SEC | Apr 10, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2012 | — |
| NT 10-K | None | Sep 28, 2011 | Jun 30, 2011 |
| NT 10-Q | Filing | May 16, 2011 | Mar 31, 2011 |
| NT 10-Q | Filing | Feb 14, 2011 | Dec 31, 2010 |
| NT 10-Q | Filing | Nov 15, 2010 | Sep 30, 2010 |
| NT 10-K | Filing | Sep 28, 2010 | Jun 30, 2010 |
| D | Filing | Jul 26, 2010 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2010 | — |
| NT 10-Q | Filing | May 14, 2010 | Mar 31, 2010 |
| EFFECT | Filing | Apr 29, 2010 | — |
| CORRESP | Letter to the SEC | Apr 28, 2010 | — |
| CORRESP | Letter to the SEC | Apr 27, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2010 | — |
| CORRESP | Letter to the SEC | Apr 6, 2010 | — |
| CORRESP | Letter to the SEC | Mar 22, 2010 | — |
| CORRESP | Letter to the SEC | Mar 17, 2010 | — |
| CORRESP | Letter to the SEC | Mar 15, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2010 | — |
| NT 10-Q | Filing | Feb 16, 2010 | Dec 31, 2009 |
| NT 10-Q | Filing | Nov 16, 2009 | Sep 30, 2009 |
| NT 10-K | Filing | Sep 28, 2009 | Jun 30, 2009 |
| CORRESP | Letter to the SEC | Apr 23, 2009 | — |
| DEFR14C | Nanoviricides inc defr14c 4-23-2009 | Apr 23, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2009 | — |
| NT 10-Q | Filing | Feb 17, 2009 | Dec 31, 2008 |
| NT 10-Q | Filing | Nov 14, 2008 | Sep 30, 2008 |
| REGDEX | Auto-generated paper document | Oct 6, 2008 | — |
| NTN 10K | Filing | Oct 1, 2008 | Jun 30, 2008 |
| NT 10-Q | Filing | May 16, 2008 | Mar 31, 2008 |
| EFFECT | Filing | Apr 11, 2008 | — |
| CORRESP | Letter to the SEC | Apr 9, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2008 | — |
| 10QSB | Nanoviricides 10-qsb 12-31-2007 | Feb 19, 2008 | Dec 31, 2007 |
| NT 10-Q | Filing | Feb 15, 2008 | Dec 31, 2007 |
| UPLOAD | Letter from the SEC | Jan 11, 2008 | — |
| SB-2 | Nanoviricides inc sb2 12-21-2007 | Jan 4, 2008 | — |
| 10QSB | Nanoviricides, inc. 10qsb 9-30-07 | Nov 19, 2007 | Sep 30, 2007 |
| NT 10-Q | Filing | Nov 15, 2007 | Sep 30, 2007 |
| 10KSB | Nanoviricides, inc. 10ksb 06-30-07 | Oct 15, 2007 | Jun 30, 2007 |
| NT 10-K | Filing | Oct 1, 2007 | Jun 30, 2007 |
| REGDEX | Auto-generated paper document | Jun 15, 2007 | — |
| REGDEX | Auto-generated paper document | Jun 15, 2007 | — |
| 10QSB | Nanoviricides, inc 10qsb 3-31-2007 | May 18, 2007 | Mar 31, 2007 |
| NT 10-Q | Filing | May 15, 2007 | Mar 31, 2007 |
| CORRESP | Letter to the SEC | Apr 5, 2007 | — |
| CORRESP | Letter to the SEC | Apr 3, 2007 | — |
| 10SB12G/A | Nanoviricides 10-sb12g/a | Mar 20, 2007 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2007 | — |
| 10QSB | Nanoviricides 10-qsb 12-31-2006 | Feb 15, 2007 | Dec 31, 2006 |
| NT 10-Q | Filing | Feb 15, 2007 | Dec 31, 2006 |
| CORRESP | Letter to the SEC | Feb 14, 2007 | — |
| 10SB12G/A | Nanoviricides 10-sb12g/a | Feb 14, 2007 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2007 | — |
| CORRESP | Letter to the SEC | Jan 17, 2007 | — |
| 10SB12G/A | Nanoviricides 10-sb12g/a | Jan 17, 2007 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2006 | — |
| 10SB12G | Filing | Nov 14, 2006 | — |
Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NNVC (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Shelton, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1379006
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.